Raras
Buscar doenças, sintomas, genes...
Poliendocrinopatia autoimune
ORPHA:282196CID-10 · E31.0CID-11 · 5B00DOENÇA RARA

Grupo de diversas condições caracterizadas por autoimunidade espontânea e multiorgânica, que tem como alvo tecidos endócrinos (adrenais, gônadas, células das ilhotas pancreáticas, paratireóide, hipófise, tireoide) e não endócrinos (gastrointestinais, tegumentares, linfáticos).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Grupo de diversas condições caracterizadas por autoimunidade espontânea e multiorgânica, que tem como alvo tecidos endócrinos (adrenais, gônadas, células das ilhotas pancreáticas, paratireóide, hipófise, tireoide) e não endócrinos (gastrointestinais, tegumentares, linfáticos).

Pesquisas ativas
2 ensaios
11 total registrados no ClinicalTrials.gov
Publicações científicas
548 artigos
Último publicado: 2026 Dec
Medicamentos
6 registrados
HYDROXYCHLOROQUINE, RIVAROXABAN, WARFARIN

Tem tratamento?

6 medicamentos registrados
Ver detalhes, fases e interações →
HYDROXYCHLOROQUINERIVAROXABANWARFARINBELIMUMABRITUXIMABFLUVASTATIN
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E31.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
18 sintomas
👁️
Olhos
10 sintomas
🫃
Digestivo
8 sintomas
🧬
Pele e cabelo
8 sintomas
🫘
Rins
6 sintomas
🩸
Sangue
5 sintomas

+ 41 sintomas em outras categorias

Características mais comuns

Granulomatose de células epitelióides não caseosas
Anormalidade da glândula tireoide
Positividade do anticorpo anti-esteroide 17alfa-hidroxilase
Morfologia anormal da musculatura
Hipogonadismo feminino
Hepatite crônica ativa
110sintomas
Sem dados (110)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 110 características clínicas mais associadas, ordenadas por frequência.

Granulomatose de células epitelióides não caseosasNon-caseating epithelioid cell granulomatosis
Anormalidade da glândula tireoideAbnormality of the thyroid gland
Positividade do anticorpo anti-esteroide 17alfa-hidroxilaseAnti-steroid 17alpha-hydroxylase antibody positivity
Morfologia anormal da musculaturaAbnormality of the musculature
Hipogonadismo femininoFemale hypogonadism

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico548PubMed
Últimos 10 anos200publicações
Pico202136 papers
Linha do tempo
2026Hoje · 2026🧪 2008Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

AIREAutoimmune regulatorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor playing an essential role to promote self-tolerance in the thymus by regulating the expression of a wide array of self-antigens that have the commonality of being tissue-restricted in their expression pattern in the periphery, called tissue restricted antigens (TRA) (PubMed:26084028). Binds to G-doublets in an A/T-rich environment; the preferred motif is a tandem repeat of 5'-ATTGGTTA-3' combined with a 5'-TTATTA-3' box. Binds to nucleosomes (By similarity). Binds to chromat

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia

A rare disease characterized by the combination of chronic mucocutaneous candidiasis, hypoparathyroidism and Addison disease. Symptoms of mucocutaneous candidiasis manifest first, followed by hypotension or fatigue occurring as a result of Addison disease. APS1 is associated with other autoimmune disorders including diabetes mellitus, vitiligo, alopecia, hepatitis, pernicious anemia and primary hypothyroidism.

OUTRAS DOENÇAS (2)
autoimmune polyendocrine syndrome type 1familial isolated hypoparathyroidism due to impaired PTH secretion
HGNC:360UniProt:O43918

Medicamentos e terapias

HYDROXYCHLOROQUINEPhase 3

Mecanismo: Toll-like receptor 7 antagonist

RIVAROXABANPhase 3

Mecanismo: Coagulation factor X inhibitor

WARFARINPhase 2

Mecanismo: Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor

BELIMUMABPhase 2

Mecanismo: Tumor necrosis factor ligand superfamily member 13B inhibitor

RITUXIMABPhase 2

Mecanismo: B-lymphocyte antigen CD20 binding agent

FLUVASTATINPhase 2

Mecanismo: HMG-CoA reductase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

364 variantes patogênicas registradas no ClinVar.

🧬 AIRE: GRCh38/hg38 21q11.2-22.3(chr21:13644166-44968483)x3 ()
🧬 AIRE: NM_000383.4(AIRE):c.133-2A>G ()
🧬 AIRE: NM_000383.4(AIRE):c.756_757del (p.Lys253fs) ()
🧬 AIRE: GRCh37/hg19 21q22.3(chr21:44762021-48097372)x1 ()
🧬 AIRE: GRCh37/hg19 21q22.13-22.3(chr21:39652840-45862615)x3 ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 26
Medicamentos catalogadosEnsaios clínicos· 6 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Poliendocrinopatia autoimune

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Revisão sistemática
Timeline de publicações
204 papers (10 anos)
#1

First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses.

Molecular therapy : the journal of the American Society of Gene Therapy2026 Feb 04

CD45RC, an isoform of the transmembrane tyrosine phosphatase CD45, regulates T and B cell antigen receptor signaling and is highly expressed on Th1 precursors, Th1 cells, T effector memory CD45RA+ cells, and most B cells. Preclinical studies have shown that anti-CD45RC monoclonal antibodies (mAbs) can prevent or control diseases such as transplant rejection, graft-versus-host disease (GvHD), Duchenne muscular dystrophy (DMD), and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED or APS-1). However, their mechanism of action remained unclear. Here, we elucidate the mechanism of anti-human CD45RC mAbs, showing that it selectively induces apoptosis in CD45RChigh T and B cells through binding to cells expressing >24 CD45RC molecules/μm2. This interaction triggers intracellular signaling without cytokine release. Cytotoxicity by apoptosis is enhanced by crosslinking with a secondary antibody. The mAb also promotes antibody-dependent cellular phagocytosis by monocyte-derived macrophages, without inducing antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, likely due to the length of CD45RC. In CD34+-humanized NSG mice, anti-CD45RC mAbs demonstrated dose-dependent depletion of CD45RChigh T and B cells and defined a minimum effective dose to prevent xenogeneic GvHD. These findings define the mechanism of action of this first-in-class anti-human CD45RC therapeutic mAb and supports its potential for the treatment of transplant rejection, GvHD, and autoimmune diseases.

#2

Real world incidence, predictors and outcomes of endocrine immune-related adverse events following immune checkpoint inhibitors.

Human vaccines & immunotherapeutics2026 Dec

Endocrine dysfunction is one of the most common immune-related adverse events (irAEs) reported in immune checkpoint inhibitors (ICIs) clinical trials. The aim of this research was to thoroughly assess the clinical features of endocrine irAEs, investigate the risk and predictive variables, and provide guidance for clinical therapy. This study performed a retrospective review of clinical data from 269 patients with malignant malignancies who underwent initial immune checkpoint inhibitor treatment at the First Bethune Hospital of Jilin University between May 2021 and October 2022.The incidence of endocrine irAEs was 31.6% (85/269), while the autoimmune polyendocrinopathy syndrome (APS) was observed in 1.1% (3/269). The median time for the first adverse reaction was 46 (33.5, 100.5) d. The occurrence of ICIs-related thyroid injury events was significant, with the incidence at 27.5% (74/269), whereas the frequency of grade 2 and higher adverse reactions was 33.8% (25/74). Female gender (OR = 2.723, 95 % CI: 1.447-5.125) and a history of chemotherapy (OR = 2.716, 95 % CI: 1.079-6.836) were distinct risk factors for thyroid injury associated with ICIs. In the 106/269 who had baseline antibody testing, the presence of anti-thyroglobulin antibodies (TGAb) (AUC = 0.717) and thyroid peroxidase antibody (TPOAb) (AUC = 0.690) could aid in predicting this injury, with TGAb demonstrating greater reliability. The prevalence of ICIs-related diabetes was 3.7% (10/269), with a higher occurrence in male patients compared to female patients, and the rate of grade 3 and above adverse reactions was 10% (3/10). The occurrence of ICIs-related pituitary inflammation was 1.1% (3/269), primarily involving pituitary hormones such as thyroid stimulating hormone (TSH) and adrenocorticotropic hormone (ACTH). The incidence of ICIs-related adrenocortical hypofunction was 0.4% (1/269), with a grade 3 adverse event. The antibody testing was performed in a nonrandom subset and thus the predictive AUC results might be affected by bias.

#3

Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.

Genes2026 Jan 29

Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy is an extremely rare autosomal recessive disorder caused by inborn errors of immunity. It is due to a loss-of-function mutation in the AIRE autoimmune regulator gene. Its manifestations include autoimmunity affecting endocrine glands, in addition to non-endocrine manifestations including dental enamel hypoplasia, alopecia areata, hepatitis, and chronic mucocutaneous candidiasis. Globally, 10 cases per million are affected by this condition, with higher incidence in highly consanguineous populations. Here, we describe a novel AIRE gene mutation in a pediatric patient from Lebanon, along with the observed phenotype. A nine-year-old boy with history of craniosynostosis presented with jaundice. His past medical history was significant for recurrent oral thrush, keratoconjunctivitis, nail dystrophy, and alopecia. Upon presentation, he had jaundice, isolated splenomegaly, and severe failure to thrive. Laboratory tests showed transaminitis, cholestasis, and hypergammaglobulinemia. Abdominal ultrasound findings were suggestive of cirrhosis with compensated portal hypertension. The differential diagnosis included viral infection, inborn errors of metabolism, and autoimmune hepatitis. Exome sequencing identified a novel homozygous pathogenic variant in the AIRE gene, NM_000383.4: c.1066dup p.(Arg356Profs*16), confirming the diagnosis. This study expands the genotypic and phenotypic spectrum of a rare inborn error of immunity in a child with chronic mucocutaneous candidiasis, enamel hypoplasia, and hepatitis.

#4

When One Gland Speaks First: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Unmasked by Isolated Hypoparathyroidism.

Cureus2026 Jan

Autoimmune polyendocrinopathy syndrome type 1 (APS-1) is a rare autosomal recessive disorder caused by pathogenic variants in the AIRE gene and classically characterized by the triad of hypoparathyroidism, chronic mucocutaneous candidiasis, and adrenal insufficiency. Although hypoparathyroidism is often the earliest manifestation, isolated and prolonged monosymptomatic presentations remain uncommon and may delay recognition of the syndrome. We report the case of a child who was first presented at four years of age with severe hypocalcemia in the setting of acute gastroenteritis and was diagnosed with hypoparathyroidism. Apart from hypomagnesemia and hyperphosphatemia, extensive workup revealed no additional autoimmune or endocrine abnormalities. Genetic testing subsequently identified a homozygous likely pathogenic stop-loss AIRE gene mutation, confirming APS-1. Over a three-year follow-up period, the patient remained clinically stable with well-controlled hypoparathyroidism, except for hypocalcemic episodes during diarrheal illnesses, and persistently normal adrenal, thyroid, pancreatic, and celiac screening. The first additional disease feature emerged three years after the initial presentation, at the age of seven years, when a fungal nail infection consistent with mucocutaneous candidiasis was noted. This case highlights the marked phenotypic variability with delayed evolution of APS-1 and underscores that isolated hypoparathyroidism, even when severe, may precede other disease components by several years. Early genetic testing in children with apparently isolated hypoparathyroidism allows anticipatory guidance, structured surveillance, and timely recognition of evolving autoimmune manifestations.

#5

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.

Journal of pediatric endocrinology & metabolism : JPEM2026 Feb 20

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is a multi-system autoimmune disorder caused by AIRE gene variants. Diagnosis can be challenging and often delayed. A specialised clinic for children and young people with APECED established in 2024 at Bristol Royal Hospital for Children, recruited patients from South-West England. We describe the diagnostic journey, disease progression and management challenges for 4 patients with APECED. All cases had a history of fungal nail infections and chronic mucocutaneous candidiasis preceding the development of endocrinopathy. Hypoparathyroidism was the most common endocrine presentation (n=3). Two patients had pancreatic exocrine dysfunction requiring pancreatic enzyme replacement. One patient had primary ovarian insufficiency (POI) aged 11. One female without evidence of POI was referred to fertility services to discuss fertility preservation. Immunomodulation was used in 2 patients; 1 received sirolimus, rituximab, corticosteroids, mycophenolate followed by ruxolitinib and 1 patient recently started ruxolitinib. Inter-speciality working is important to detect and manage a range of comorbidities as new immunomodulatory therapies that aim to prevent disease progression are emerging. Proactive screening for certain autoantibodies such as 21-OH can help predict patients at risk of certain endocrinopathies and may provide an opportunity for early intervention to prevent long-term morbidity.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC209 artigos no totalmostrando 197

2026

Real world incidence, predictors and outcomes of endocrine immune-related adverse events following immune checkpoint inhibitors.

Human vaccines & immunotherapeutics
2026

Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.

Genes
2026

When One Gland Speaks First: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Unmasked by Isolated Hypoparathyroidism.

Cureus
2026

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.

Journal of pediatric endocrinology & metabolism : JPEM
2025

A novel heterozygous pathogenic AIRE variant causing autoimmunity but not infectious susceptibility.

Journal of human immunity
2026

AIRE's Complex Role Beyond Promiscuous Gene Expression.

Immunological reviews
2026

Intravenous Glucose Tolerance Tests in Predicting Diabetes Onset in APECED: A Retrospective Cohort Study.

Journal of the Endocrine Society
2026

Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening.

Endocrinology, diabetes & metabolism
2025

Addison's disease in patients with autoimmune primary ovarian insufficiency: a concise guide for gynecologists and obstetricians.

Ginekologia polska
2026

Oral and Craniofacial Development and Immunology.

Advances in experimental medicine and biology
2025

Case Report: Clinical and molecular features of a radiosensitive autoimmune polyendocrine syndrome type 1 patient with oral carcinoma.

Frontiers in genetics
2026

First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

Intrathymic T-cell ontogeny: Crossroad between immune competence and tolerance.

The Journal of allergy and clinical immunology
2026

Balancing IL-17-mediated protection and IFN-γ-driven pathology at mucocutaneous barriers.

Trends in immunology
2025

Head and Neck Malignancies in Autoimmune Polyendocrine Syndrome Type 1 (APS-1/APECED): A Scoping Review of Molecular Pathogenesis, Clinical Features, and Outcomes.

International journal of molecular sciences
2025

Case Report: Life-threatening overlap of hemophagocytic syndrome and atypical hemolytic uremic syndrome in a patient with autoimmune polyglandular syndrome type 1 successfully treated with targeted immunotherapy.

Frontiers in immunology
2025

Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Frontiers in immunology
2025

Recurrent Hypoglycemia in a child With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy-associated Hepatitis.

Journal of clinical and experimental hepatology
2025

Autoimmune hepatitis and immune dysregulation: A case series.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
2025

Precision T cell correction platform for inborn errors of immunity.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

Immune cell subsets in autoimmune polyendocrine syndrome type I.

Scientific reports
2025

Delayed diagnosis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a Vietnamese adolescent male presenting with hypotension.

BMJ case reports
2025

When Hashimoto's Thyroiditis Masks Biermer's Disease: A Revealing Case of Autoimmune Polyendocrinopathy.

Cureus
2025

High-resolution transcriptional impact of AIRE: effects of pathogenic variants p.Arg257Ter, p.Cys311Tyr, and polygenic risk variant p.Arg471Cys.

Frontiers in immunology
2025

Pernicious Anemia in a Pediatric Patient With Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

JCEM case reports
2025

Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1.

Scandinavian journal of immunology
2025

The Great Mimicker: Langerhans Cell Histiocytosis Mimicking Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy.

Fetal and pediatric pathology
2025

Renal disorders in Autoimmune Polyendocrinopathy Candidiasis Ectodermal dystrophy (APECED): a systematic review.

BMC pediatrics
2024

Bronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report.

BMC pulmonary medicine
2025

Uncovering ASO-Targetable Deep Intronic AIRE Variants: Insights and Therapeutic Implications.

DNA and cell biology
2024

Where AIRE we now? Where AIRE we going?

Current opinion in allergy and clinical immunology
2024

Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.

Allergologie select
2024

A deep intronic splice-altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion.

Science translational medicine
2025

Recalcitrant extensive dermatophytosis in twin brothers with APECED syndrome.

Pediatric dermatology
2024

Decreased T-cell response against latent cytomegalovirus infection does not correlate with anti-IFN autoantibodies in patients with APECED.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
2024

Lymphocyte-Directed Immunomodulation Remits Thymoma-Associated Autoimmune Pneumonitis.

Journal of clinical immunology
2024

Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 - A National Cohort Study.

Journal of clinical immunology
2024

JAK Inhibition Immunotherapy for APS-1.

The New England journal of medicine
2024

The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.

The New England journal of medicine
2024

Long-term remission of candidiasis with fermented lingonberry mouth rinse in an adult patient with APECED.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort.

The Journal of clinical endocrinology and metabolism
2025

Progressive Impairment of Prepubertal Growth in Children With APECED.

The Journal of clinical endocrinology and metabolism
2024

Early recognition of the APECED rash can accelerate the diagnosis of APECED.

Clinical immunology communications
2023

Recurrent venous thrombosis - an unusual first presentation of autoimmune polyendocrinopathy syndrome type 3B.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2024

Novel Insights into the Autoimmunity from the Genetic Approach of the Human Disease.

Advances in experimental medicine and biology
2023

APECED and the place of AIRE in the puzzle of the immune network associated with autoimmunity.

Scandinavian journal of immunology
2024

VKH with APECED in a Two-Year-Old Child: A Rare Concomitant Diagnosis in an Unprecedented Age.

Ocular immunology and inflammation
2024

Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.

Biomedicines
2024

Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.

Immunological reviews
2023

Genetic Susceptibility to Fungal Infections.

Advanced biomedical research
2024

Dysregulated germinal center reaction with expanded T follicular helper cells in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy lymph nodes.

The Journal of allergy and clinical immunology
2023

Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations.

Science translational medicine
2023

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-Associated Hepatitis.

ACG case reports journal
2025

Early-onset Chronic Keratitis as the First Presenting Component of Autoimmune Polyendocrine Syndrome Type 1: A Case Report and Review of the Literature.

Journal of clinical research in pediatric endocrinology
2023

Initiation of Continuous rhPTH Infusion With Insulin Pump in an Inpatient Setting.

JCEM case reports
2023

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Nature
2023

Validation of a murine proteome-wide phage display library for identification of autoantibody specificities.

JCI insight
2023

T-cell receptor repertoire analysis of CD4-positive T cells from blood and an affected organ in an autoimmune mouse model.

Genes to cells : devoted to molecular & cellular mechanisms
2023

Alopecia areata and occurrence of vitiligo and hypothyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

Pediatric dermatology
2023

Analysis of a series of Italian APECED patients with autoimmune hepatitis and gastro-enteropathies.

Frontiers in immunology
2023

Ocular features of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

BMJ case reports
2023

Autoimmune regulator (Aire) deficiency results in reduced memory CD8+ T cells after Listeria monocytogenes infection in a murine model.

FEBS letters
2023

Autoimmune Polyendocrinopathy in a Pediatric Patient Presenting With Multisystem Inflammatory Syndrome in Children (MIS-C).

Cureus
2023

CTLA4-Ig Effectively Controls Clinical Deterioration and Immune Condition in a Murine Model of Foxp3 Deficiency.

Journal of clinical immunology
2023

An Extraordinary Case of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) Syndrome Misdiagnosed as Juvenile Idiopathic Arthritis on Admission.

Case reports in immunology
2023

Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis.

Endocrinology, diabetes & metabolism case reports
2023

Validation of a murine proteome-wide phage display library for the identification of autoantibody specificities.

bioRxiv : the preprint server for biology
2023

A Rare Case of Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy Syndrome: Dental Perspective on Diagnosis and Management.

International journal of clinical pediatric dentistry
2023

Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases.

Calcified tissue international
2023

Pubertal development and hypogonadism in males with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a retrospective study.

European journal of endocrinology
2023

Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype.

Frontiers in immunology
2023

Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED.

Frontiers in pediatrics
2023

Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases.

Frontiers in immunology
2023

Autoimmune regulator (AIRE): Takes a hypoxia-inducing factor 1A (HIF1A) route to regulate FOXP3 expression in PCOS.

American journal of reproductive immunology (New York, N.Y. : 1989)
2023

A non-classical presentation of APECED in a family with heterozygous R203X AIRE gene mutation.

Journal of endocrinological investigation
2022

Inborn errors of immunity and related microbiome.

Frontiers in immunology
2022

Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED.

Frontiers in endocrinology
2022

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and esophageal rupture by candida infection: A case report and review.

Journal de mycologie medicale
2023

LAMP2 regulates autophagy in the thymic epithelium and thymic stroma-dependent CD4 T cell development.

Autophagy
2022

Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review.

Diabetes, metabolic syndrome and obesity : targets and therapy
2022

Clinical Characteristics in the Longitudinal Follow-Up of APECED Syndrome in Southern Croatia-Case Series.

Genes
2022

Generation and Characterization of iPS Cells Derived from APECED Patients for Gene Correction.

Frontiers in endocrinology
2021

Mycophenolate-Induced Colitis in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients.

JPGN reports
2022

Oral manifestations of autoimmune polyglandular syndrome type 1.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2022

Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.

The Journal of clinical investigation
2022

Clinical, histological and genetic findings in a donor with a clinical history of type 1 Autoimmune Polyendocrinopathy Syndrome.

American journal of ophthalmology case reports
2021

Rituximab as Maintenance Therapy in Type 1 Autoimmune Pancreatitis: An Italian Experience.

Pancreas
2022

Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants.

Orphanet journal of rare diseases
2021

Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1).

Frontiers in endocrinology
2021

Hypoadrenalism as the Single Presentation of Autoimmune Polyglandular Syndrome Type 1.

Journal of the Endocrine Society
2022

Long-term Outcome of Kidney Transplantation in 6 Patients With Autoimmune Polyendocrinopathy-candidiasis-ectodermal Dystrophy.

Transplantation
2022

French-Canadian families from Saguenay-Lac-Saint-Jean: a new founder population for APECED.

Endocrine
2021

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.

Frontiers in pediatrics
2019

Autoimmune thyroiditis - track towards autoimmune polyendocrinopathy type III.

Archive of clinical cases
2022

Pregnancy Outcome in Women With APECED (APS-1): A Multicenter Study on 43 Females With 83 Pregnancies.

The Journal of clinical endocrinology and metabolism
2022

Loss of AIRE-Mediated Immune Tolerance and the Skin.

The Journal of investigative dermatology
2021

[Chronic mucocutaneous candidiasis associated with autoimmunity and ectodermal dysplasia. A case report].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2021

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections.

Clinical immunology (Orlando, Fla.)
2021

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.

Frontiers in immunology
2021

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity.

The Journal of allergy and clinical immunology
2021

Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?

Current opinion in immunology
2021

Infections in the monogenic autoimmune syndrome APECED.

Current opinion in immunology
2021

Infections and demanding endocrine care contribute to increased mortality in patients with APECED.

European journal of endocrinology
2021

Fatal autoimmune pneumonitis requiring bilobectomy and omental flap repair in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

Respiratory medicine case reports
2021

Case Report: Severe Hypocalcemic Episodes Due to Autoimmune Enteropathy.

Frontiers in endocrinology
2021

AIRE Gene Mutation Presenting at Age 2 Years With Autoimmune Retinopathy and Steroid-Responsive Acute Liver Failure: A Case Report and Literature Review.

Frontiers in immunology
2021

Case Report: Rituximab Improved Epileptic Spasms and EEG Abnormalities in an Infant With West Syndrome and Anti-NMDAR Encephalitis Associated With APECED.

Frontiers in neurology
2021

Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?

Italian journal of pediatrics
2021

Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review.

Expert review of clinical immunology
2021

Atypical presentation of autoimmune polyglandular syndrome type 1 in the fifth decade.

BMJ case reports
2021

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.

The Journal of allergy and clinical immunology
2021

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.

The Journal of experimental medicine
2021

Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic Link.

Frontiers in endocrinology
2022

Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis.

Pediatric research
2021

AIRE deficiency, from preclinical models to human APECED disease.

Disease models & mechanisms
2021

Late-onset autoimmune polyendocrine syndrome type 1: a case report and literature review.

Immunologic research
2020

An AIREless Breath: Pneumonitis Caused by Impaired Central Immune Tolerance.

Frontiers in immunology
2021

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy in Two Siblings: Same Mutations but Very Different Phenotypes.

Genes
2021

Acquired pure red cell aplasia and T cell large granular lymphocytic leukaemia in patients with autoimmune polyglandular syndrome type 1.

BMC medical genomics
2022

The Prevalence of Selective and Partial Immunoglobulin A Deficiency in Patients with Autoimmune Polyendocrinopathy.

Immunological investigations
2021

Case Report: Dental Findings Can Aid in Early Diagnosis of APECED Syndrome.

Frontiers in dental medicine
2021

A Patient With AIRE Mutation Who Presented With Severe Diarrhea and Lung Abscess.

The Pediatric infectious disease journal
2020

Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report.

Translational lung cancer research
2021

NLRP3 Inhibition Ameliorates Severe Cutaneous Autoimmune Manifestations in a Mouse Model of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-Like Disease.

The Journal of investigative dermatology
2020

Pubertal development and premature ovarian insufficiency in patients with APECED.

European journal of endocrinology
2021

Impact of periprocedural subcutaneous parathyroid hormone on control of hypocalcaemia in APS-1/APECED patients undergoing invasive procedures.

Clinical endocrinology
2021

Microarray diagnosis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy caused by a novel homozygous intragenic AIRE deletion.

Journal of paediatrics and child health
2021

Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.

Journal of endocrinological investigation
2020

In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency.

Fertility and sterility
2020

A novel variant in AIRE causing a rare, non‑classical autoimmune polyendocrine syndrome type 1.

Molecular medicine reports
2021

APECED-Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort.

Hepatology (Baltimore, Md.)
2020

Neutralizing natural anti-IL-17F autoantibodies protect Autoimmune Polyendocrine Syndrome Type 1 (APS-1) patients from asthma.

Clinical immunology (Orlando, Fla.)
2020

IL-22 Paucity in APECED Is Associated With Mucosal and Microbial Alterations in Oral Cavity.

Frontiers in immunology
2020

Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.

The Journal of clinical endocrinology and metabolism
2020

Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq.

eLife
2020

A case report and literature review: Identification of a novel AIRE gene mutation associated with Autoimmune Polyendocrine Syndrome Type 1 in East Asians.

Medicine
2020

Dual functions of Aire CARD multimerization in the transcriptional regulation of T cell tolerance.

Nature communications
2020

Severe Phenotype of APECED (APS1) Increases Risk for Structural Bone Alterations.

Frontiers in endocrinology
2020

Patients With APECED Have Increased Early Mortality Due to Endocrine Causes, Malignancies and infections.

The Journal of clinical endocrinology and metabolism
2019

Primary Immunodeficiency with Severe Multi-Organ Immune Dysregulation.

Case reports in immunology
2020

Paroxysmal strabismus and stridor acquired in childhood: Do not overlook calcemia!

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2019

A novel compound heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrine syndrome type 1.

Annals of pediatric endocrinology & metabolism
2020

Amino Acid Polymorphisms in Hla Class II Differentiate Between Thyroid and Polyglandular Autoimmunity.

The Journal of clinical endocrinology and metabolism
2020

Association of Autoimmune Regulator Gene Rs2075876 Variant, but Not Gene Expression with Alopecia Areata in Males: A Case-control Study.

Immunological investigations
2020

Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.

Immunological investigations
2019

[Autoimmune polyglandular disorders in myotonic dystrophy].

Problemy endokrinologii
2020

Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy.

The Journal of clinical endocrinology and metabolism
2019

Infertility and pregnancy in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: More than just primary ovarian failure?

American journal of reproductive immunology (New York, N.Y. : 1989)
2019

Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

Science translational medicine
2019

Autoimmune Polyendocrinopathy.

The Journal of clinical endocrinology and metabolism
2019

Profiling Autoantibodies against Salivary Proteins in Sicca Conditions.

Journal of dental research
2019

AIRE expression controls the peripheral selection of autoreactive B cells.

Science immunology
2019

Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases.

International journal of dermatology
2019

Serotonin and tryptophan metabolites, autoantibodies and gut microbiome in APECED.

Endocrine connections
2019

Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Immunological reviews
2018

[Endocrine complications in primary immunodeficiency diseases].

Orvosi hetilap
2018

Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.

Frontiers in immunology
2018

Hypoparathyroidism in children: a study of eight cases.

La Tunisie medicale
2018

Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.

Journal of immunology (Baltimore, Md. : 1950)
2019

Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED.

The Journal of clinical endocrinology and metabolism
2018

The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.

Clinical immunology (Orlando, Fla.)
2018

Oral Tongue Malignancies in Autoimmune Polyendocrine Syndrome Type 1.

Frontiers in endocrinology
2018

A novel AIRE gene mutation in a patient with autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy revealed by alopecia areata.

JAAD case reports
2018

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α.

Journal of visualized experiments : JoVE
2018

Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-like Autoimmune Disease.

Journal of immunology (Baltimore, Md. : 1950)
2018

[Rheumatological manifestations in primary immunodeficiency diseases].

Orvosi hetilap
2018

Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.

Cellular immunology
2018

The Role of AIRE in the Immunity Against Candida Albicans in a Model of Human Macrophages.

Frontiers in immunology
2018

In vitro maturation of oocytes from excised ovarian tissue in a patient with autoimmune ovarian insufficiency possibly associated with Epstein-Barr virus infection.

Reproductive biology and endocrinology : RB&E
2018

Integrity of IKK/NF-κB Shields Thymic Stroma That Suppresses Susceptibility to Autoimmunity, Fungal Infection, and Carcinogenesis.

BioEssays : news and reviews in molecular, cellular and developmental biology
2018

Rapid whole-genome sequencing identifies a novel AIRE variant associated with autoimmune polyendocrine syndrome type 1.

Cold Spring Harbor molecular case studies
2018

Beyond APECED: An update on the role of the autoimmune regulator gene (AIRE) in physiology and disease.

Autoimmunity reviews
2017

Association pernicious anemia and autoimmune polyendocrinopathy: a retrospective study.

Journal of medicine and life
2017

Approach to a Child with Primary Immunodeficiency Made Simple.

Indian dermatology online journal
2017

Group 6. Modalities and frequency of monitoring of patients with adrenal insufficiency. Patient education.

Annales d'endocrinologie
2018

Dominant-negative loss of function arises from a second, more frequent variant within the SAND domain of autoimmune regulator (AIRE).

Journal of autoimmunity
2018

Update on Aire and thymic negative selection.

Immunology
2017

Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation.

United European gastroenterology journal
2017

Autoimmune Regulator Deficiency Results in a Decrease in STAT1 Levels in Human Monocytes.

Frontiers in immunology
2017

Clonal Analysis of Regulatory T Cell Defect in Patients with Autoimmune Polyendocrine Syndrome Type 1 Suggests Intrathymic Impairment.

Scandinavian journal of immunology
2017

GAD antibody-associated limbic encephalitis in a young woman with APECED.

Endocrinology, diabetes & metabolism case reports
2017

A new mutation site in the AIRE gene causes autoimmune polyendocrine syndrome type 1.

Immunogenetics
2017

Childhood Polyarthritis As Early Manifestation of Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy Syndrome.

Frontiers in immunology
2017

Chronic Candidiasis in Children.

Current allergy and asthma reports
2017

Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis.

Cell host & microbe
2017

Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children.

Italian journal of pediatrics
2017

Oral lichen planus in childhood: a case series.

International journal of dermatology
2017

DNA breaks and chromatin structural changes enhance the transcription of autoimmune regulator target genes.

The Journal of biological chemistry
2017

Unexplained cyanosis caused by hepatopulmonary syndrome in a girl with APECED syndrome.

Journal of pediatric endocrinology & metabolism : JPEM
2017

[Cancer and mycoses and literature review].

Bulletin de la Societe de pathologie exotique (1990)
2017

Pathogenic and Protective Autoantibodies in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED).

Antibodies (Basel, Switzerland)
2016

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.

Clinical & translational immunology
2016

IL-6-specific autoantibodies among APECED and thymoma patients.

Immunity, inflammation and disease
2016

Autoimmune Regulator Expression in DC2.4 Cells Regulates the NF-κB Signaling and Cytokine Expression of the Toll-Like Receptor 3 Pathway.

International journal of molecular sciences
2016

Autoimmune polyendocrinopathy and hypophysitis after Puumala hantavirus infection.

Endocrinology, diabetes & metabolism case reports
2016

Ocular manifestations of autoimmune polyendocrinopathy syndrome type 1.

Current opinion in ophthalmology
2016

Novel Findings into AIRE Genetics and Functioning: Clinical Implications.

Frontiers in pediatrics
Ver todos os 209 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Poliendocrinopatia autoimune.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Poliendocrinopatia autoimune

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses.
    Molecular therapy : the journal of the American Society of Gene Therapy· 2026· PMID 41174880mais citado
  2. Real world incidence, predictors and outcomes of endocrine immune-related adverse events following immune checkpoint inhibitors.
    Human vaccines & immunotherapeutics· 2026· PMID 41800705mais citado
  3. Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.
    Genes· 2026· PMID 41751543mais citado
  4. When One Gland Speaks First: Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Unmasked by Isolated Hypoparathyroidism.
    Cureus· 2026· PMID 41728462mais citado
  5. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a case series and experience from a UK tertiary paediatric hospital.
    Journal of pediatric endocrinology & metabolism : JPEM· 2026· PMID 41712317mais citado
  6. A novel heterozygous pathogenic AIRE variant causing autoimmunity but not infectious susceptibility.
    J Hum Immun· 2025· PMID 41608501recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:282196(Orphanet)
  2. MONDO:0017278(MONDO)
  3. GARD:21116(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q675311(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Poliendocrinopatia autoimune
Compêndio · Raras BR

Poliendocrinopatia autoimune

ORPHA:282196 · MONDO:0017278
CID-10
E31.0 · Insuficiência poliglandular auto-imune
CID-11
Ensaios
2 ativos
Medicamentos
6 registrados
MedGen
UMLS
C0085409
EuropePMC
Wikidata
Wikipedia
Papers 10a
Evidência
🥇 Rev. sistemática
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades